TMBIM1 and hepatocellular carcinoma: Our findings confirmed that the expression of TMBIM1 on the membranes of late endosomes and lysosomes significantly reduced SASP, suppressed CS and inhibited the occurrence of HCC, thereby filling a gap in the role of CS and HCC and providing insights into the impact of TMBIM1 on other tumors.